Making Sense of Allergic Rhinitis: A Comprehensive Look at Causes, Co-Morbidities, and Effective Treatment Strategies

This activity is supported by an educational grant from Chattem, Inc.

Making Sense of Allergic Rhinitis: A Comprehensive Look at Causes, Co-Morbidities, and Effective Treatment Strategies

Rupal Patel Mansukhani, PharmD

Clinical Assistant Professor

Ernest Mario School of Pharmacy

Rutgers University

Piscataway, New Jersey

Lucio Volino, PharmD

Clinical Assistant Professor

Ernest Mario School of Pharmacy

Rutgers University

Piscataway, New Jersey

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty

Rupal Patel Mansukhani, PharmD

Lucio Volino, PharmD

Pharmacy Times Office of Continuing Professional Education

Planning Staff—David Heckard; Maryjo Dixon, RPh; Steve Lin, PharmD, RPh; and Donna Fausak

Pharmacy Times Editorial Staff—Bea Riemschneider and Kirk McKay

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial inter-ests to disclose.

Educational Objectives

At the conclusion of this knowledge-based CPE activity, pharmacists should be bet-ter prepared to:

• Review the incidence and basic pathophysiology of allergic rhinitis (AR).
• Describe the common symptoms, presentation, and complications of AR.
• Discuss current management of AR, including allergen avoidance, immunotherapy, and pharmacotherapy, including new and emerging dosage formulations.
• Apply counseling strategies to help address common patient questions and misconceptions to achieve optimal symptom relief.

Release date: February 12, 2014

Expiration date: February 12, 2016

Target audience: Pharmacists

Type of activity: Knowledge

Estimated time to complete activity: 2 hours

Fee: Free

Click here to view this activity.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-004-H01-P. The activity is available for CE credit through February 12, 2016.